An experimental Toxoplasma gondii dose response challenge model to study therapeutic or vaccine efficacy in cats.
High numbers of Toxoplasma gondii oocysts in the environment are a risk factor to humans. The environmental contamination might be reduced by vaccinating the definitive host, cats. An experimental challenge model is necessary to quantitatively assess the efficacy of a vaccine or drug treatment. Prev...
Main Authors: | Jan B W J Cornelissen, Joke W B van der Giessen, Katsuhisa Takumi, Peter F M Teunis, Henk J Wisselink |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/25184619/?tool=EBI |
Similar Items
-
Effectiveness and costs of interventions to reduce the within-farm Toxoplasma gondii seroprevalence on pig farms in the Netherlands
by: Dorien M. Eppink, et al.
Published: (2021-07-01) -
Toxoplasma gondii Infection in Stray Cats
by: M Arbabi, et al.
Published: (2007-04-01) -
Toxoplasma gondii Infection in Stray Cats
by: H Hooshyar, et al.
Published: (2007-03-01) -
SEROLOGICAL SURVEY OF TOXOPLASMA GONDII IN DOGS AND CATS
by: Faiz Ahmad, Azhar Maqbool, Ashar Mahfooz and Sikandar Hayat
Published: (2001-01-01) -
Toxoplasma gondii seroprevalence varies by cat breed.
by: Kärt Must, et al.
Published: (2017-01-01)